Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-010118
Filing Date
2025-03-04
Accepted
2025-03-04 19:03:52
Documents
1
Period of Report
2025-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1741133025.html 4  
1 FORM 4 wk-form4_1741133025.xml 4 7394
  Complete submission text file 0001628280-25-010118.txt   8838
Mailing Address C/O WATSON PHARMA INC 360 MOUNT KEMBLE AVE MORRISTOWN NJ 07960
Business Address
BOYER ANDREW S (Reporting) CIK: 0001239546 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38485 | Film No.: 25707632

Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Issuer) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)